HealthTech is redefining how care is delivered, scaled, and sustained with advances in artificial intelligence, surgical robotics, and wearable sensors.

Biotechnology represents a long-term structural growth theme with innovation serving as both catalyst and compass for future opportunity.

The Global X HealthTech ETF (HEAL) seeks to provide exposure to companies driving healthcare's technological revolution.

By leveraging advances in genomics and artificial intelligence, companies working to treat cancer can tap into numerous potential growth drivers.

Novel therapeutic agents can differentiate themselves via a host of factors, which may also impact potential revenue opportunities. Charting Disruption.